Subject: Notice on the convening of the Ordinary General Meeting of Celon Pharma S.A. on June 22, 2022 with draft resolutions<\/p>\n\n\n\n
Legal basis: Article 56 subs. 1 point 2 of the Act on Public Offering \u2013 current and periodical information<\/p>\n\n\n\n
Content of the report:<\/p>\n\n\n\n
The Management Board of Celon Pharma S.A. (\u201cthe Company\u201d), acting pursuant to Article 395 \u00a7 1, Article 399 \u00a7 1, Article 402 (1) and Article 402 (2) of the Commercial Companies Code, hereby convenes the Ordinary General Meeting on 22 June 2022 to be held at 10:00 AM at the Company’s Research And Development Center in Kazu\u0144 at ul. Marymoncka 15.<\/p>\n\n\n\n
The suggested agenda is as follows:<\/p>\n\n\n\n
1. Opening of the Ordinary General Meeting.<\/p>\n\n\n\n
2. Election of the Chairperson of the Ordinary General Meeting.<\/p>\n\n\n\n
3. Confirmation that the Ordinary General Meeting has been convened correctly and has the capacity to adopt binding resolutions.<\/p>\n\n\n\n
4. Adoption of the agenda of the Ordinary General Meeting.<\/p>\n\n\n\n
5. Election of the Returning Committee of the Ordinary General Meeting.<\/p>\n\n\n\n
6. Examination of the Management Board\u2019s report on the Company\u2019s business activities for the year 2021, the Company\u2019s Financial Statements for the financial year 2021, the Management Board\u2019s recommendation on the coverage of loss and payment of the dividend for the financial year 2021.<\/p>\n\n\n\n
7. Examination of the Supervisory Board\u2019s report for the financial year 2021 taking into account requirements specified in the Best Practice for GPW-Listed Companies 2021.<\/p>\n\n\n\n
8. Adoption of a resolution on approving the Management Board\u2019s report on the Company\u2019s business activities for the year 2021.<\/p>\n\n\n\n
9. Adoption of a resolution on approving the Company\u2019s Financial Statements for the financial year 2021;<\/p>\n\n\n\n
10. Adoption of a resolution on the coverage of loss and payment of the dividend for the financial year 2021.<\/p>\n\n\n\n
11. Adoption of a resolution on approving the Supervisory Board\u2019s report for the financial year 2021 taking into account requirements specified in the Best Practice for GPW-Listed Companies 2021.<\/p>\n\n\n\n
12. Adoption of resolutions on acknowledging the fulfilment of duties by Members of the Management Board in 2021.<\/p>\n\n\n\n
13. Adoption of resolutions on acknowledging the fulfilment of duties by Members of the Supervisory Board in 2021.<\/p>\n\n\n\n
14. Adoption of a resolution on issuing an opinion on the “Report on remuneration of Members of the Management Board and the Supervisory Board of Celon Pharma S.A. for the period 01.01.2021-31.12.2021\u201d.<\/p>\n\n\n\n
15. Adoption of a resolution on expanding the Company\u2019s scope of activity and amending the Articles of Association of the Company.<\/p>\n\n\n\n
16. Any other business.<\/p>\n\n\n\n
17. Closing of the General Meeting.<\/p>\n\n\n\n
In this current report, the Company is attaching the full notice on convening the Ordinary General Meeting and draft resolutions.<\/p>\n\n\n\n
At the same time the Company informs that the Supervisory Board\u2019s report referred to in points 7 and 11 of the agenda, as well as the report on remuneration of Members of the Management Board and the Supervisory Board referred to in point 14 of the agenda will be made available at a later date, immediately after they have been adopted by the Company\u2019s Supervisory Board.<\/p>\n","protected":false},"excerpt":{"rendered":"